STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Oculis (OCS) announced the vesting and settlement of Restricted Stock Units (RSUs) for two company directors - Anthony Rosenberg and Arshad Khanani. The transactions occurred in May 2025 as part of previously granted RSU compensation packages. This type of transaction is a routine part of executive compensation where RSUs convert to actual shares based on a predetermined vesting schedule.
Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company.

Attachments


FAQ

What type of transaction did Oculis (OCS) announce on June 3, 2025?

Oculis announced the vesting and settlement of Restricted Stock Units (RSUs) for two company directors, Anthony Rosenberg and Arshad Khanani.

Who were the directors involved in the Oculis RSU vesting announcement?

The RSU vesting involved two Oculis directors: Anthony Rosenberg and Arshad Khanani.

When did the RSU vesting for Oculis directors take place?

The RSU vesting took place in May 2025.

What are RSUs in the context of the Oculis announcement?

RSUs (Restricted Stock Units) are a form of executive compensation that convert to actual company shares according to a predetermined vesting schedule.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Latest SEC Filings

OCS Stock Data

1.09B
48.60M
6.31%
31.25%
0.02%
Biotechnology
Healthcare
Link
Switzerland
Zug